LAMISIL
LOE ApproachingNDAORALGRANULE
Approved
Sep 2007
Lifecycle
LOE Approaching
Competitive Pressure
30/100
Clinical Trials
1
Data completeness
2/8 — Basic
Drug data last refreshed 17h ago · AI intelligence enriched 1w ago
AI summarySynthesized from FDA + DailyMed + ClinicalTrials.gov data
LAMISIL is an oral granule antifungal medication approved by Novartis in 2007. The specific indication and mechanism of action are not disclosed in available data, but oral granule formulations are typically used for systemic fungal infections. This small-molecule drug represents a convenient dosage form for patients requiring oral antifungal therapy.
LOE Approaching
Product is in late-stage lifecycle with moderate competitive pressure (30/100), suggesting a mature brand team managing decline and preparing for loss of exclusivity.
Mechanism of Action
Mechanism of action data is being enriched from DailyMed and FDA sources. Check back soon for updated drug intelligence.
Indications
Indication data is being enriched from DailyMed and FDA labeling. Check back soon for approved therapeutic uses.
Clinical Trials (1)
Safety and Effectiveness of Giving Lamisil to HIV-Positive Subjects With Thrush Who Have Not Responded to Fluconazole Treatment
30 enrolled
Candidiasis, OralHIV Infections
Career Relevance
Working on LAMISIL offers limited new career growth due to zero linked job openings and an approaching loss of exclusivity. This role is best suited for professionals seeking stability in a mature product or experience managing late-lifecycle brand transitions.
Brand Manager
Worked on LAMISIL at Novartis? Share your interview experience or compensation data (+7 days Pro)
Data Sources
- Drug label: DailyMed / FDA
- Clinical trials: ClinicalTrials.gov
- Patent data: FDA Orange Book
- Spending data: CMS Medicare
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.